rs1132785

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_198682.3(GYPE):​c.38G>C​(p.Gly13Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 4 hom., cov: 43)
Exomes 𝑓: 0.31 ( 5 hom. )
Failed GnomAD Quality Control

Consequence

GYPE
NM_198682.3 missense, splice_region

Scores

18
Splicing: ADA: 0.001664
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.39

Publications

16 publications found
Variant links:
Genes affected
GYPE (HGNC:4705): (glycophorin E (MNS blood group)) The protein encoded by this gene is a sialoglycoprotein and a type I membrane protein. It is a member of a gene family with GPA and GPB genes. This encoded protein might carry the M blood group antigen. GYPA, GYPB, and GYPE are organized in tandem on chromosome 4. This gene might have derived from an ancestral gene common to the GPB gene by gene duplication. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004680425).
BP6
Variant 4-143880509-C-G is Benign according to our data. Variant chr4-143880509-C-G is described in ClinVar as Benign. ClinVar VariationId is 402918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYPENM_198682.3 linkc.38G>C p.Gly13Ala missense_variant, splice_region_variant Exon 2 of 4 ENST00000358615.9 NP_941391.2 P15421
GYPENM_002102.4 linkc.38G>C p.Gly13Ala missense_variant, splice_region_variant Exon 2 of 4 NP_002093.2 P15421
LOC105377459XR_001741861.1 linkn.1463+14433C>G intron_variant Intron 9 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYPEENST00000358615.9 linkc.38G>C p.Gly13Ala missense_variant, splice_region_variant Exon 2 of 4 1 NM_198682.3 ENSP00000351430.4 P15421

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
39796
AN:
132948
Hom.:
4
Cov.:
43
show subpopulations
Gnomad AFR
AF:
0.306
Gnomad AMI
AF:
0.283
Gnomad AMR
AF:
0.302
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.347
Gnomad SAS
AF:
0.327
Gnomad FIN
AF:
0.341
Gnomad MID
AF:
0.319
Gnomad NFE
AF:
0.284
Gnomad OTH
AF:
0.284
GnomAD2 exomes
AF:
0.262
AC:
54614
AN:
208744
AF XY:
0.263
show subpopulations
Gnomad AFR exome
AF:
0.299
Gnomad AMR exome
AF:
0.251
Gnomad ASJ exome
AF:
0.197
Gnomad EAS exome
AF:
0.315
Gnomad FIN exome
AF:
0.315
Gnomad NFE exome
AF:
0.251
Gnomad OTH exome
AF:
0.231
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.306
AC:
415445
AN:
1355624
Hom.:
5
Cov.:
83
AF XY:
0.309
AC XY:
208690
AN XY:
675718
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.334
AC:
10114
AN:
30252
American (AMR)
AF:
0.357
AC:
14973
AN:
41988
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
7367
AN:
24436
East Asian (EAS)
AF:
0.366
AC:
12785
AN:
34920
South Asian (SAS)
AF:
0.337
AC:
26835
AN:
79640
European-Finnish (FIN)
AF:
0.374
AC:
18974
AN:
50754
Middle Eastern (MID)
AF:
0.330
AC:
1803
AN:
5468
European-Non Finnish (NFE)
AF:
0.296
AC:
305220
AN:
1032452
Other (OTH)
AF:
0.312
AC:
17374
AN:
55714
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.332
Heterozygous variant carriers
0
19719
39438
59158
78877
98596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11860
23720
35580
47440
59300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.299
AC:
39829
AN:
133042
Hom.:
4
Cov.:
43
AF XY:
0.306
AC XY:
19877
AN XY:
64958
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.306
AC:
10626
AN:
34696
American (AMR)
AF:
0.302
AC:
4100
AN:
13560
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
865
AN:
3056
East Asian (EAS)
AF:
0.347
AC:
1504
AN:
4334
South Asian (SAS)
AF:
0.327
AC:
1405
AN:
4300
European-Finnish (FIN)
AF:
0.341
AC:
3214
AN:
9414
Middle Eastern (MID)
AF:
0.335
AC:
83
AN:
248
European-Non Finnish (NFE)
AF:
0.284
AC:
17282
AN:
60782
Other (OTH)
AF:
0.283
AC:
530
AN:
1874
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.345
Heterozygous variant carriers
0
1731
3462
5192
6923
8654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.238
Hom.:
1405
ExAC
AF:
0.342
AC:
41455

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency (no homozygotes in ExAC) -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.0010
DANN
Benign
0.085
DEOGEN2
Benign
0.0045
T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0016
N
LIST_S2
Benign
0.48
.;T
M_CAP
Benign
0.0011
T
MetaRNN
Benign
0.0047
T;T
MetaSVM
Benign
-0.94
T
PhyloP100
-2.4
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.66
N;N
REVEL
Benign
0.0040
Sift
Benign
1.0
T;T
Sift4G
Benign
0.33
T;T
Polyphen
0.015
B;B
Vest4
0.10
MPC
0.0071
ClinPred
0.00037
T
GERP RS
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Varity_R
0.025
gMVP
0.035
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0017
dbscSNV1_RF
Benign
0.25
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1132785; hg19: chr4-144801662; COSMIC: COSV62261499; API